Domainex invests in NanoTemper MST technology to advance fragment-based drug discovery services
Home  »  Community News  »  Domainex invests in NanoTemper MST technology to advance fragment-based drug discovery services
Dec
19
ragupathyrenganathan
Domainex invests in NanoTemper MST technology to advance fragment-based drug discovery services
Drug Discovery, Formulation Discussion, Pharma News
0